Semaglutide Questions: Short Answers From Studies
What people ask most about Semaglutide
What can the studies tell you about semaglutide? They cover weight, blood sugar, side effects, and heart harm. Each number comes from a study or FDA paper listed here. You can check the key semaglutide clinical trials. The questions below give short answers.
What each study answer means for you
Which body hormone does Semaglutide act like?
Semaglutide is a 31-amino-acid chain, which is made of protein parts. It acts like the human hormone GLP-1, which is made after meals. GLP-1 helps control blood sugar. The body's own GLP-1 fades in ~2 minutes. The GLP-1 drug lasts about 168 hours, so shots can be weekly. The FDA cleared it for type 2 diabetes in 2017. Weight care followed in 2021 and liver disease in 2025 [1][13].
How may Semaglutide change blood sugar and hunger?
In three body areas, semaglutide acts like GLP-1. In the pancreas, it raises insulin when blood sugar rises. In the brain, it makes hunger-curbing cells more active. It quiets cells that drive hunger. The stomach empties more slowly too. People ate 24% less on average in studies [11][18]. Your result may differ.
What has the FDA cleared Semaglutide to treat?
The FDA has cleared several uses. Shots of 0.5/1.0/2.0 mg treat type 2 diabetes from 2017. A 2.4 mg shot treats weight in adults and teens age ≥12. Those uses came in 2021/2022. Pills of 7/14 mg treat the same diabetes from 2019. Since August 2025, a 2.4 mg shot also treats some adults with MASH liver scars [1][8].
Is Semaglutide the body's own GLP-1?
No. Semaglutide acts much like GLP-1 and matches about ~94% of it. Scientists changed parts 8, 34, and 26 along the drug's chain. Those changes make the GLP-1 drug last. The body's GLP-1 fades in ~2 minutes. Semaglutide lasts ~168 hours. It acts at the same places on cells, but it isn't the body's own hormone [13].
Why is Semaglutide called a peptide drug?
A peptide is a short chain of protein parts. Semaglutide is a 31-amino-acid chain, so each link is one protein part. The drug acts like human GLP-1. The GLP-1 drug is larger than many simple medicines. Its shape affects how it is made, stored, and taken.
Which health problems has Semaglutide been tested for?
SUSTAIN studied type 2 diabetes. STEP studied long-term weight care. SELECT studied heart risk. In 2025, ESSENCE studied MASH liver disease. A stage 2 study also looked at alcohol use [9]. By 2025, the FDA had cleared the three main uses plus MASH [8]. Alcohol use wasn't a cleared use. Your doctor can explain the difference.
How long may Semaglutide remain in your body?
Its half-life is about 168 hours, or 7 days. Half-life is the time needed for half the drug to leave. That long stay allows weekly shots. Some drug remains about 5 weeks after the last shot. Hunger and blood sugar effects may continue during that time [13]. You may still notice changes after stopping.
When did Semaglutide start working in studies?
Blood sugar began changing within days. People felt less hungry within 1–2 weeks. STEP found weight loss of ≥5% by weeks 12–16. By then, people had reached the full study dose. The steps took 16–20 weeks to reach 2.4 mg. The slow rise was meant to ease stomach trouble [1]. Your timing may differ.
What may change first after Semaglutide starts?
Blood sugar may fall in the first week. Study doses began at 0.25 mg each week. They rose every four weeks to curb stomach trouble. Clear weight loss often came near the full dose. That was around weeks 16–20. The drug didn't wait that long to act [1]. The steps slowed the dose rise, not the first effect.
Which Semaglutide side effect was most common?
The main problems were nausea, diarrhea, and vomiting. At 2.4 mg, nausea hit 43.9%. Diarrhea hit 29.7%, and vomiting hit 24.5%. Some 99.5% of these cases weren't serious [5]. Gallstones affected 1.6% versus 0.7% on a placebo. Sudden pancreas swelling was reported, but no cancer rise was proved. Weight also returned after people stopped [4]. Ask your doctor about these risks.
Which serious harms can Semaglutide cause?
The FDA label carries its strongest warning for thyroid cancer. That warning came from tumors in certain thyroid cells in rats and mice. Human risk wasn't known in 2024. Other concerns include sudden pancreas swelling and gallbladder disease. SUSTAIN-6 found more eye trouble when blood sugar fell fast. A 2024 FDA alert also warned about compounded forms [19]. Ask a doctor about your own risks.
What did long Semaglutide studies find about safety?
The stage 3 STEP, SUSTAIN, and SELECT studies followed thousands of people. Serious harm was uncommon. The FDA reviewed safety before clearing three uses. SELECT then watched people for four years. It found no new kind of harm beyond shorter studies [2][14]. The strong thyroid warning still stands. Stomach and bowel trouble remains common. The drug isn't risk free. A doctor can judge your own risk.
What did STEP find about Semaglutide and hair loss?
STEP reported hair loss in about 3% on semaglutide. The placebo groups reported about 1% [16]. Doctors describe this as a short spell of hair shedding across the head. Fast weight loss may bring it on. The drug may not harm the hair roots. Hair loss was more common after weight loss of ≥20%. Hair often grows back. Your doctor can check other causes.
Has Semaglutide been linked to depression?
Reports after sale raised concern about depression and thoughts of suicide. A 12-month study compared people with much the same health. It found no clear rise in mood or brain harm [20]. Other studies didn't prove semaglutide was the cause. The FDA still watches reports. Obesity can affect mood too, which clouds the answer. Tell your doctor about any mood change.
Did weight return when people stopped Semaglutide?
Yes. Much of the weight returned in STEP 1. People regained 11.6 points on average within 1 year [4]. At week 120, loss from the start was 5.6%. The greatest loss had been 17.3%. Some gains in blood sugar and heart risk faded too. The study treated obesity as a long-term illness. Your care may need to last.
What does STEP say about losing 30 pounds on Semaglutide?
STEP 1 followed 1,961 people for 68 weeks. Average loss was 14.9% [1]. For someone starting at 220 lbs, or ~100 kg, that is ~32.8 lbs. The study gives only a group average at week 68. So 30 lbs was close to that average. It wasn't assured. Start weight, food, dose, and missed shots can change your result.
Did Semaglutide reduce deep belly fat in studies?
MRI scans in STEP found loss in deep belly fat. This fat lies around the organs. The SELECT 208-week report measured waists. Semaglutide brought a −7.7 cm change. A placebo brought −1.3 cm over four years [14]. Smaller waists went with better signs of heart health. The scans can't tell how much you might lose.
How may Semaglutide help people lose weight?
In one brain area, semaglutide acts like GLP-1. It makes hunger-curbing cells more active and quiets hunger-driving cells [11]. The stomach empties more slowly too. People stay full longer and eat less. Studies found 24% less food eaten on average. A 168-hour half-life keeps this effect going all week [13]. Your result may differ.
What did one study find for Semaglutide and tirzepatide?
Both drugs act like the GLP-1 hormone made after meals. Tirzepatide also acts like a second gut hormone. SURMOUNT-5 compared them in 751 people for 72 weeks. Average loss was 20.2% with tirzepatide. It was 13.7% with semaglutide [7]. By 2025, the GLP-1 drug had more heart results, including SELECT and SUSTAIN-6. Your choice takes more than one study.
How is compounded Semaglutide different?
A pharmacy mixes compounded semaglutide for a patient. The FDA doesn't check each form before sale. In July 2024, the FDA warned about dose errors. Some people needed hospital care. The agency also found false labels [19]. The FDA doesn't first confirm the product's safety, strength, or results. Ask your doctor which kind you have.
How did Semaglutide pills compare with shots?
In 2023, OASIS 1 tested a 50 mg pill in 667 people for 68 weeks. Average loss was 15.1% for the full group. It was 17.4% among those who stayed through the end. A placebo brought 2.4% [6]. Stomach trouble hit 80% versus 46%. A helper in the pill let 0.4–1% reach blood. Blood levels from 50 mg were like the shot [13]. You can't treat the doses as equal.
Which Semaglutide dose was highest in studies?
The approved top weight dose is a 2.4 mg/week shot. In 2025, STEP UP tested 7.2 mg in 803 people for 72 weeks. Average loss was −18.7% versus −15.6% at 2.4 mg [17]. Also, 31.2% on 7.2 mg lost ≥25%. The FDA began a fast review in 2025. That amount was still under study. Your label sets the approved dose.
Where did Semaglutide study doses begin?
Weight studies and the approved label began weekly shots at 0.25 mg. That step lasted four weeks and changed little weight [1]. It showed how well people handled the drug. For diabetes pills, the first step was 3 mg each day for 30 days. Each study schedule raised the dose slowly. Your doctor sets the real plan.
When did Semaglutide side effects feel worst?
The weeks when doses rose brought the most stomach and bowel trouble. With the usual 2.4 mg shot schedule, that meant weeks 4–16. Nausea was most common at the start and after each dose rise. STEP found trouble often eased after 4–8 weeks at one dose [5]. Your own trouble may last longer.
What did one Semaglutide study find about alcohol?
Studies found no direct drug clash with alcohol. Low blood sugar is less likely without insulin or sulfonylureas. In 2025, a stage 2 study assigned 48 adults to care by chance. Semaglutide cut alcohol craving and heavy drinking days [9]. The GLP-1 drug may affect reward in the brain and nerves. The small study didn't settle use for alcohol. This isn't drinking advice for you.
Which medicines may clash with Semaglutide?
One GLP-1 review found no large change in the total amount of other pills reaching blood [15]. A slower stomach did delay their highest blood level. Insulin can raise the risk of low blood sugar. Sulfonylureas, pills that raise insulin, can do the same. Some pills can cause harm after a small change in blood level. Your doctor needs your full drug list to check timing.
Did people feel tired while taking Semaglutide?
Some people in STEP felt tired [5]. Eating less and losing weight fast may have played a part. The studies didn't prove the drug was the direct cause. Tiredness often came while doses rose. At 2.4 mg, it was more common than with a placebo then. It often eased once the dose stayed level. Your doctor can check other causes.
How often did Semaglutide cause diarrhea in STEP?
Diarrhea was common in STEP. At 2.4 mg, it hit 29.7%. A placebo hit 15.9% [5]. Most cases came while doses rose. They often eased after the dose stayed level. The GLP-1 drug slows the stomach and changes bowel motion. Of all stomach and bowel side effects, 99.5% weren't serious. Severe or lasting diarrhea needs your doctor.
Do approved Semaglutide shots need mixing?
No. Approved shots come as liquid in a filled pen. They don't need mixing. Material sold for lab research isn't the approved medicine. Its form, strength, and shelf life may differ from the pen. Lab workers may add germ-free water, but those steps don't apply to approved shots. Follow the label on your pen.
How can you check insurance cover for Semaglutide?
Coverage changes by use and health plan. Type 2 diabetes often gets wider cover than weight care. Many US plans treat the two uses in different ways. The study results can't tell what your plan will pay. Call your health plan or clinic. Have the use and drug name ready when you ask.